Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Drug Development Trends in China
Drug Development Trends in China Summary China has emerged as a critical player in global drug development, driven by robust innovation. The pharmaceutical industry in China has seen a surge in drug development activities in recent years, with an increasing focus on innovative therapies such as CAR- ... Read More
-
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Strategic Intelligence: AI in drug discovery
Strategic Intelligence: AI in drug discovery Summary In recent years, the pharma industry has been taken over by a wave of digital transformation, leading to the integration of advanced technologies across different aspects of the pharma value chain. Artificial intelligence (AI) and big data are at ... Read More
-
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024 provides an overview of Metabolic Dysfunction-Associated Steatohepa ... Read More
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024 provides an overview of Metabolic Dysfunction-Ass ... Read More
-
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
Sepsis: Epidemiology Forecast to 2033
Sepsis: Epidemiology Forecast to 2033 Summary Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and t ... Read More
-
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Limb-Girdle Muscular Dystrophy therapeutics. In 2024, more than 111,000 diagnosed prevalent cases of LGMD are anticipated in the 16 cou ... Read More
-
Gonorrhea (GN): Competitive Landscape
Gonorrhea (GN): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Gonorrhea therapeutics. In 2024, more than 3.7 million diagnosed incident cases of GN are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Multiple System Atrophy (MSA): Competitive Landscape
Multiple System Atrophy (MSA): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Multiple System Atrophy therapeutics. In 2024, more than 226,000 diagnosed prevalent cases of MSA are anticipated in the 16 countries covered i ... Read More
-
Glycogen Storage Disorders (GSD): Competitive Landscape
Glycogen Storage Disorders (GSD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Glycogen Storage Disorders therapeutics. In 2024, more than 2,000 diagnosed incident cases of GSD are anticipated in the 16 countries covere ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region ... Read More
-
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Devel ... Read More
-
Biosensors in North America
Biosensors in North America Summary Biosensors in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players inc ... Read More
-
Biosensors in South America
Biosensors in South America Summary Biosensors in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key fin ... Read More
-
Uterine Leiomyoma: Competitive Landscape
Uterine Leiomyoma: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Uterine Leiomyoma therapeutics. In 2024, more than 16 million incident cases of UL are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Dysmenorrhea: Competitive Landscape
Dysmenorrhea: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Dysmenorrhea therapeutics. In 2024, more than 647 million diagnosed prevalent cases of DM are anticipated in the 16 countries covered in GlobalData’s epidemiolo ... Read More
-
Thematic Intelligence: Microbiome-Based Therapeutics
Thematic Intelligence: Microbiome-Based Therapeutics Summary The microbiome, encompassing a vast array of microorganisms inhibiting the human body, has garnered significant attention for its role in health and disease. Recent advancements in microbiome research along with recent approvals of micro ... Read More
-
Pharmaceutical Drug Development Annual Review - 2023
Pharmaceutical Drug Development Annual Review - 2023 Summary This report investigates the year 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based ana ... Read More
-
Focal Segmental Glomerulosclerosis: Competitive Landscape
Focal Segmental Glomerulosclerosis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. In 2024, more than 36,000 diagnosed incident cases of FSGS are anticipated in the 16 coun ... Read More
-
Acute coronary syndrome: Competitive Landscape
Acute coronary syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute coronary syndrome therapeutics. In 2024, more than 7.8 million hospitalized incident cases of ACS are anticipated in the 16 countries covered i ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More
-
Chronic Urticaria: Competitive Landscape
Chronic Urticaria: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in chronic urticaria therapeutics. In 2024, more than 60 million diagnosed prevalent cases of CU are anticipated in the 16 countries covered in GlobalData’s e ... Read More
-
Thematic Intelligence: The Future of Healthcare
Thematic Intelligence: The Future of Healthcare Summary This report is part of GlobalData's Future of Industry report series. It focuses on the healthcare sector.Several technologies will drive the future of healthcare. They include 3D printing, robotics, preventive medicine, and digital therapeutic ... Read More
Research Assistance
